207 related articles for article (PubMed ID: 37373137)
41. [Expression of microRNA-152 in colorectal cancer and its relationship with prognosis].
Wang Y; Yuan W; Ma X; Ma J
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):763-766. PubMed ID: 27784461
[No Abstract] [Full Text] [Related]
42. Significance of microRNA-330-5p/TYMS Expression Axis in the Pathogenesis of Colorectal Tumorigenesis.
Karimi L; Jaberi M; Asadi M; Zarredar H; Zafari V; Bornehdeli S; Niknam S; Kermani TA
J Gastrointest Cancer; 2022 Dec; 53(4):965-970. PubMed ID: 34651293
[TBL] [Abstract][Full Text] [Related]
43. Circular RNA circ_0007142 regulates cell proliferation, apoptosis, migration and invasion via miR-455-5p/SGK1 axis in colorectal cancer.
Wen T; Wu H; Zhang L; Li K; Xiao X; Zhang L; Zhang Y
Anticancer Drugs; 2021 Jan; 32(1):22-33. PubMed ID: 32889894
[TBL] [Abstract][Full Text] [Related]
44. DNA-methylation-mediated silencing of miR-486-5p promotes colorectal cancer proliferation and migration through activation of PLAGL2/IGF2/β-catenin signal pathways.
Liu X; Chen X; Zeng K; Xu M; He B; Pan Y; Sun H; Pan B; Xu X; Xu T; Hu X; Wang S
Cell Death Dis; 2018 Oct; 9(10):1037. PubMed ID: 30305607
[TBL] [Abstract][Full Text] [Related]
45. miRNAs-Based Molecular Signature for
Milanesi E; Dobre M; Bucuroiu AI; Herlea V; Manuc TE; Salvi A; De Petro G; Manuc M; Becheanu G
J Immunol Res; 2020; 2020():4927120. PubMed ID: 32676506
[TBL] [Abstract][Full Text] [Related]
46. miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4.
Azar MRMH; Aghazadeh H; Mohammed HN; Sara MRS; Hosseini A; Shomali N; Tamjidifar R; Tarzi S; Mansouri M; Sarand SP; Marofi F; Akbari M; Xu H; Shotorbani SS
Int Immunopharmacol; 2021 Mar; 92():107355. PubMed ID: 33429333
[TBL] [Abstract][Full Text] [Related]
47. Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in colorectal cancer.
Chen P; Xi Q; Wang Q; Wei P
Med Oncol; 2014 Oct; 31(10):235. PubMed ID: 25216869
[TBL] [Abstract][Full Text] [Related]
48. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
[TBL] [Abstract][Full Text] [Related]
49. Overexpression of miR-223 correlates with tumor metastasis and poor prognosis in patients with colorectal cancer.
Li ZW; Yang YM; Du LT; Dong Z; Wang LL; Zhang X; Zhou XJ; Zheng GX; Qu AL; Wang CX
Med Oncol; 2014 Nov; 31(11):256. PubMed ID: 25270282
[TBL] [Abstract][Full Text] [Related]
50. Expression level of miR-383-5p in colorectal cancer patients following neoadjuvant chemotherapy and its clinical significance in the prognosis.
Sun X; Wang X; Dong G; Zhao Z; Song J
Minerva Med; 2023 Aug; 114(4):485-490. PubMed ID: 32700862
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA-93-5p expression in tumor tissue and its tumor suppressor function via targeting programmed death ligand-1 in colorectal cancer.
Chen YL; Wang GX; Lin BA; Huang JS
Cell Biol Int; 2020 May; 44(5):1224-1236. PubMed ID: 32068322
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA-383-5p acts as a potential prognostic biomarker and an inhibitor of tumor cell proliferation, migration, and invasion in breast cancer.
Zhang J; Kong X; Shi Q; Zhao B
Cancer Biomark; 2020; 27(4):423-432. PubMed ID: 31903982
[TBL] [Abstract][Full Text] [Related]
53. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
[TBL] [Abstract][Full Text] [Related]
54. MiR-9-5p suppresses cell metastasis and epithelial-mesenchymal transition through targeting FOXP2 and predicts prognosis of colorectal carcinoma.
Wang WX; Yu HL; Liu X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6467-6477. PubMed ID: 31378886
[TBL] [Abstract][Full Text] [Related]
55. MicroRNA-30a-5p
Outeiro-Pinho G; Barros-Silva D; Aznar E; Sousa AI; Vieira-Coimbra M; Oliveira J; Gonçalves CS; Costa BM; Junker K; Henrique R; Jerónimo C
J Exp Clin Cancer Res; 2020 Jun; 39(1):98. PubMed ID: 32487203
[TBL] [Abstract][Full Text] [Related]
56. MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis.
Papageorgiou SG; Kontos CK; Diamantopoulos MA; Bouchla A; Glezou E; Bazani E; Pappa V; Scorilas A
Dis Markers; 2017; 2017():2046545. PubMed ID: 29463948
[TBL] [Abstract][Full Text] [Related]
57. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.
Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E
Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.
Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S
Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286
[TBL] [Abstract][Full Text] [Related]
59. Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs.
Bullock MD; Pickard K; Mitter R; Sayan AE; Primrose JN; Ivan C; Calin GA; Thomas GJ; Packham GK; Mirnezami AH
Oncotarget; 2015 Mar; 6(9):7262-79. PubMed ID: 25788261
[TBL] [Abstract][Full Text] [Related]
60. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.
Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y
Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
